ZEAL Network SE 10.08.2016 12:22 Dissemination of a Voting Rights Announcement, transmitted by DGAP - a service of EQS Group AG. The issuer is solely responsible for the content of this announcement. --------------------------------------------------------------------------- The Company has received a form TR-1 on 09 August 2016 from Credit Suisse Group AG. TR-1 notification of major interest in shares 1. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attached: ZEAL Network SE 2. Reason for the notification: An acquisition or disposal of voting rights 3. Full name of person(s) subject to the notification obligation: CREDIT SUISSE GROUP AG 4. Full name of shareholder(s) (if different from 3.): PLEASE SEE SECTION 9 5. Date of the transaction and date on which the threshold is crossed or reached: 05/08/2016 6. Date on which issuer notified: 09/08/2016 7. Threshold(s) that is/are crossed or reached: 3% 8. Notified details: A: Voting rights attached to shares Class/type of shares: Ordinary GB00BHD66J44 Situation previous to the triggering transaction Number of Shares: 289,492 Number of Voting Rights: 289,492 Resulting situation after the triggering transaction Number of shares (Direct): N/A Number of voting rights (Direct): N/A Number of voting rights (Indirect): Not reportable % of voting rights (Direct): N/A % of voting rights (Indirect): Not reportable B: Qualifying Financial Instruments N/A C: Financial Instruments with similar economic effect to Qualifying Financial Instruments Type of financial instrument: N/A Exercise price: Expirations date: Exercise/Conversion period: Number of voting rights instrument refers to: % of voting rights: Total (A+B+C) Number of voting rights: Not reportable Percentage of voting rights: Not reportable 9. Chain of controlled undertakings through which the voting rights and/or the financial instruments are effectively held: 1. Credit Suisse Group AG 2. Credit Suisse AG 3. Credit Suisse Investments (UK) 4. Credit Suisse Investments Holdings (UK) 5. Credit Suisse Securities (EUROPE) Limited 1. Credit Suisse Group AG 2. Credit Suisse AG 3. Credit Suisse Asset Management International Holding Ltd 4. Credit Suisse Holding Europe (Luxembourg) S.A. 5. Credit Suisse Fund Management S.A. Proxy Voting: 10. Name of the proxy holder: 11. Number of voting rights proxy holder will cease to hold: 12. Date on which proxy holder will cease to hold voting rights: 10.08.2016 The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases. Archive at www.dgap.de --------------------------------------------------------------------------- Language: English Company: ZEAL Network SE 5th Floor One New Change EC4M 9AF London United Kingdom Internet: www.zeal-network.co.uk End of Announcement DGAP News-Service ---------------------------------------------------------------------------
DGAP-PVR: ZEAL Network SE: Release according to Article 26,
Top 10 Most Recent News Articles
Top 5 Most Recently Viewed Articles
Explore Urban Leisure: Four Exciting Experiences in Panama
Four Ways to Experience Urban Leisure in Panama Marriott International has put together four exciting suggestions for enjoying a lively vacation in Panama's urban environment. This dynamic city is an ideal spot for urban leisure, offering easy access by air, a mix of historical landmarks, and contemporary architecture. Discovering Panamá Viejo and Casco Viejo Begin your...
Continue Reading
Understanding P/E Ratios: A Deep Dive into PTC Inc.
Analyzing P/E Ratios: What Investors Should Know In the ever-evolving landscape of the stock market, PTC Inc. has captured attention with its recent price of $170.90, reflecting a modest increase of 1.77%. Despite this recent uptick, the company has experienced a downturn of 8.94% over the past month and a 3.27% decline over the past year. This fluctuation raises an...
Continue Reading
Exploring the Rapid Growth of the Multicore Processors Market
Understanding the Multicore Processors Market Expansion As the digital age continues to thrive, the multicore processors market is also witnessing an impressive trajectory, thanks to the growing need for advanced computing solutions across various industries. Multicore processors, which allow for simultaneous processing on multiple cores, are essential for delivering...
Continue Reading
Switch Therapeutics Welcomes Dr. Holtzman to Scientific Team
Switch Therapeutics' New Direction with Dr. David M. Holtzman Switch Therapeutics, a pioneering biotechnology firm focused on developing advanced RNA therapeutics for central nervous system diseases, has recently announced an exciting new chapter in its growth. The company has appointed Dr. David M. Holtzman, a leading expert in neurology, to its Scientific Advisory...
Continue Reading
Market Movements: Major Stock Declines in Pre-Market Trading
Market Overview and Key Stock Movements This morning, U.S. stock futures looked to open higher, with the Dow futures up by approximately 0.1%. However, some major stocks faced notable declines in pre-market trading sessions, prompting attention from investors. Inspire Medical Systems Faces Setback Inspire Medical Systems, Inc. experienced a significant drop in pre-market...
Continue Reading